NBIX - Neurocrine Biosciences Inc. (NBIX) CEO Kevin Gorman on Q4 2020 Results - Earnings Call Transcript

Neurocrine Biosciences, Inc. (NBIX) Q4 2020 Earnings Conference Call February 04, 2021 04:30 PM ET Company Participants Todd Tushla - Vice President, Investor Relations Kevin Gorman - Chief Executive Officer Matt Abernethy - Chief Financial Officer Eiry Roberts - Chief Medical Officer Eric Benevich - Chief Commercial Officer Kyle Gano - Chief Business Development and Strategy Officer Conference Call Participants Biren Amin - Jefferies Paul Matteis - Stifel Tazeen Ahmad - Bank of America Josh Schimmer - Evercore Laura Christianson - Cowen Brian Skorney - Baird Tessa Romero - JPMorgan Paul Choi - Goldman Sachs Jeff Hung - Morgan Stanley Vamil Divan - Mizuho Securities Yatin Suneja - Guggenheim partners Joseph Stringer - Needham & Company Charles Duncan - Cantor Fitzgerald Marc Goodman - SVB Leerink David Amsellem - Piper Sandler Presentation Operator Good day, everyone, and welcome to today's Neurocrine Biosciences Reports Fourth Quarter and Year End 2020 Results.

For further details see:

Neurocrine Biosciences, Inc. (NBIX) CEO Kevin Gorman on Q4 2020 Results - Earnings Call Transcript